Drug Resistant Malarial Parasite Versus Natural Plant Alkaloids

Malaria is a significant public health concern in developed countries. Every year, the epidemic destroys a vast amount of citizens and has an economic impact on many nations. Resistance of the causative factor, the plasmodium parasite, to current treatments such as mefloquine, artemisinin-based combination therapy (ACT), and chloroquine is a major problem in control and prevention of malaria across the world. This necessitates a hasty search for new compounds, especially those derived from natural resources like medicinal plants. Plants, especially used in Ayurveda, may offer bioactive compounds and lead structures that can be used to produce modified variants with improved activity and/or lower toxicity. Alkaloids have been identified as essential phytoconstituents with intriguing biological properties over time. Quinine, an alkaloid isolated from the Cinchona flower, was the first effective antimalarial compound. The impact of different plant-derived alkaloids on the malarial parasite, which has established resistance to existing synthetic drugs due to concurrent usage, is the subject of this review.

Alkaloids, Antimalarial, Malaria, Malarial parasite, Quinine

1. National vector borne disease programme: malaria situation in India. Ministry of health & welfare, Delhi, Government of India. http://www.nvbdcp.gov.in/doc/malaria1.pdf. [Google Scholar] [Crossref]

2. Saxena S, Neerja Pant Jain DC. Antimalarial agents from plant sources. Current Science, 2003; 5(9):1314-30. [Google Scholar] [Crossref]

3. Trape, J.F., Pison, G., Spiegel, A., Enel, C., Rogier, C., 2002. Combating malaria in Africa. Trends Parasitol. 18, 224–230. [Google Scholar] [Crossref]

4. Shah NK, Dhillon GP, Dash AP, Arora U, Meshnick SR, Valecha N. Antimalarial drug resistance of Plasmodium falciparum in India: changes over time and space. The Lancet infectious diseases. 2011 Jan 1;11(1):57-64. [Google Scholar] [Crossref]

5. Kaushik NK, Bagavan A, Rahuman AA, Mohanakrishnan D, Kamaraj C, Elango G, et al. Antiplasmodial potential of selected medicinal plants from eastern Ghats of South India. Exp Parasitol. 2013;134:26–32. [Google Scholar] [Crossref]

6. Bhattacharyya, D.; Rajavel, A.; Natarajan, R.; Mohapatra, P.; Jambulingam, P.; Mahanta, J.; Prakash, A. Faunal richness and the checklist of Indian mosquitoes (Diptera: Culicidae). Check List 2014, 10, 1342–1358. [Google Scholar] [Crossref]

7. Nagpal BN, Sharma VP. Indian Anophelines. Oxford & IBH. Co; 1994. [Google Scholar] [Crossref]

8. Gilles HM. The malaria parasites. In: Warrell DA, Gilles HM, editors. Essential malariology. Arnold; 1993. pp. 12–34. [Google Scholar] [Crossref]

9. WHO. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg 2000;94(Suppl 1): S1-90. [Google Scholar] [Crossref]

10. Singh V, Mishra N, Awasthi G, Dash AP, Das A. Why is it important to study malaria epidemiology in India? Trends Parasitol. 2009;25:452–457. [Google Scholar] [Crossref]

11. Government of India, Annual Report 1995-96.DGHS,New Delhi [Google Scholar] [Crossref]

12. Kumar A, Valecha N, Jain T, Dash AP. Burden of malaria in India: retrospective and prospective view. Am J Trop Med Hyg. 2007;77:69–78. [Google Scholar] [Crossref]

13. White NJ. Counter perspective: artemisinin resistance: facts, fears, and fables. Am J Trop Med Hyg. 2012;87:785. [Google Scholar] [Crossref]

14. Bloland, P.B. Drug Resistance in Malaria; World Health Organization: Geneva, Switzerland, 2001. [Google Scholar] [Crossref]

15. Chinappi, M.; Via, A.; Marcatili, P.; Tramontano, A. On the mechanism of chloroquine resistance in Plasmodium falciparum. PLoS ONE 2010, 5, e14064. [Google Scholar] [Crossref]

16. Mbengue, A.; Bhattacharjee, S.; Pandharkar, T.; Liu, H.; Estiu, G.; Stahelin, R.V.; Rizk, S.S.; Njimoh, D.L.; Ryan, Y.; Chotivanich, K.; et al. A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria. Nature 2015, 520, 683–687. [Google Scholar] [Crossref]

17. Krogstad, D.J.; Gluzman, I.Y.; Kyle, D.E.; Oduola, A.M.J.; Martin, S.K.; Milhous, W.K. Schlesinger PHEfflux of chloroquine from Plasmodium falciparum: Mechanism of chloroquine resistance. Science 1987, 238, 1283–1285. [Google Scholar] [Crossref]

18. Bray, P.G.; Janneh, O.; Ward, S.A. Chloroquine uptake and activity is determined by binding to ferriprotoporphyrin IX in Plasmodium falciparum. Novartis Found. Symp. 1999, 226, 252–264 [Google Scholar] [Crossref]

19. Cooper, R.A.; Hartwig, C.L.; Ferdig, M.T. pfcrt is more than the Plasmodium falciparum chloroquine resistance gene: A functional and evolutionary perspective. Acta Trop. 2005, 94, 170–180. [Google Scholar] [Crossref]

20. Akhoon, B.A.; Singh, K.P.; Varshney, M.; Gupta, S.K.; Shukla, Y.; Gupta, S.K. Understanding the mechanism of atovaquone drug resistance in Plasmodium falciparum cytochrome b mutation Y268S using computational methods. PLoS ONE 2014, 9, e110041. [Google Scholar] [Crossref]

21. Sirichaiwat, C.; Intaraudom, C.; Kamchonwongpaisan, S.; Vanichtanankul, J.; Thebtaranonth, Y.; Yuthavong, Y. Target guided synthesis of 5-benzyl-2,4-diamonopyrimidines: Their antimalarial activities and binding affinities to wild type and mutant dihydrofolate reductases from Plasmodium falciparum. J. Med. Chem. 2004, 47, 345–354. [Google Scholar] [Crossref]

22. Dassonville-Klimpt, A.; Jonet, A.; Pillon, M.; Mullié, C.; Sonnet, P. Mefloquine derivatives: Synthesis, mechanisms of action, antimicrobial activities. In Science against Microbial Pathogens: Communicating Current Research and Technological Advances; Méndez-Vilas, A., Ed.; Formatex Publishers: Badarjoz, Spain, 2011; Volume 3, pp. 23–35. [Google Scholar] [Crossref]

23. Price, R.N.; Nosten, F.; Luxemburger, C.; Kham, A.; Brockman, A.; Chongsuphajaisiddhi, T.; White, N.J. Artesunate versus artemether in combination with mefloquine for the treatment of multidrug-resistant falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 1995, 89, 523–527. [Google Scholar] [Crossref]

24. Vinayak, S.; Alam, M.T.; Mixson-Hayden, T.; McCollum, A.M.; Sem, R.; Shah, N.K.; Lim, P.; Muth, S.; Rogers, W.O.; Fandeur, T.; et al. Origin and evolution of sulfadoxine resistant Plasmodium falciparum. PLoS Pathog. 2010, 6, e1000830. [Google Scholar] [Crossref]

25. R. Kaur and S. Arora, “Alkaloids-important therapeutic secondary metabolites of plant origin,” Journal of Critical Reviews, vol. 2, no. 3, pp. 1–8, 2015. [Google Scholar] [Crossref]

26. P. A. Onguen´ e, F. Ntie-Kang, L. L. Lifongo, J. C. Ndom, ´ W. Sipp, and L. M. Mbaze, “*e potential of anti-malarial compounds derived from African medicinal plants. Part I: a pharmacological evaluation of alkaloids and terpenoids,” Malaria Journal, vol. 2, no. 1, p. 449, 2013. [Google Scholar] [Crossref]

27. S. Cheenpracha, T. Ritthiwigrom, and S. Laphookhieo, “Alstoniaphyllines A-C, unusual nitrogenous derivatives from the bark of Alstonia macrophylla,” Journal of Natural Products, vol. 76, no. 4, pp. 723–726, 2013. [Google Scholar] [Crossref]

28. G. Ma, Z. Sun, Z. Sun et al., “Antimalarial diterpene alkaloids from the seeds of Caesalpinia minax,” Fitoterapia, vol. 95, pp. 234–239, 2014. [Google Scholar] [Crossref]

29. M. Fadaeinasab, H. Taha, P. N. Fauzi, H. M. Ali, and A. Widyawaruyanti, “Anti-malarial activity of isoquinoline alkaloids from the stem bark of Actinodaphne macrophylla,” Natural Product Communications, vol. 10, no. 9, pp. 1541-1542, 2015. [Google Scholar] [Crossref]

30. M. Kubo, W. Yatsuzuka, S. Matsushima et al., “Antimalarial phenanthroindolizine alkaloids from Ficus septica,” Chemical and Pharmaceutical Bulletin, vol. 64, no. 7, pp. 957–960, 2016. [Google Scholar] [Crossref]

31. P. Wangchuk, P. A. Keller, S. G. Pyne et al., “A new protoberberine alkaloid from Meconopsis simplicifolia (D. Don) Walpers with potent antimalarial activity against a multidrug resistant Plasmodium falciparum strain,” Journal of Ethnopharmacology, vol. 150, no. 3, pp. 953–959, 2013. [Google Scholar] [Crossref]

32. E. Tuenter, K. Segers, K. B. Kang et al., “Antiplasmodial activity, cytotoxicity and structure-activity relationship study of cyclopeptide alkaloids,” Molecules, vol. 22, p. 224, 2017. [Google Scholar] [Crossref]

33. E. Tuenter, V. Exarchou, A. Balde et al., “Cyclopeptide al- ´ kaloids from Hymenocardia acida,” Journal of Natural Products, vol. 79, no. 7, pp. 1746–1751, 2016. [Google Scholar] [Crossref]

34. C. Wang, J. Wan, Z. Mei, and X. Xang, “Acridone alkaloids with cytotoxic and antimalarial activities from Zanthoxylum simullans Hance,” Pharmacognosy Magazine, vol. 10, no. 37, pp. 73–76, 2014. [Google Scholar] [Crossref]

• Emerging Biologic Therapies in Autoimmune Diseases: Focus on Pemphigus Vulgaris, Generalized Myasthenia Gravis, and Psoriasis
• Monosodium Glutamate (MSG) Promotes the Contraction of Duodenal Visceral Smooth Muscle Ex Vivo in Rat
• Genotypic and Phenotypic Detection of Multidrug-Resistant Mycobacterium Tuberculosis among HIV Patients Attending Tuberculosis Reference Centres in Northwest, Nigeria
• Pleomorphic Adenoma of the Accessory Salivary Glands of the Nasopharynx: A Rare Location – Case Report and Literature Review
• Experiences of Medical Social Workers on Family Dynamics and Hospitalisation of Patients with Chronic Health Conditions at University College Hospital, Ibadan